Rivaroxaban (Xarelto®): Guide de la pratique officinale

J Douxfils, S Michel, C Beauloye, M Goethals, P Hainaut, H Heidbuchel, C Hermans, B Ickx, K Jochmans, S Mottes, F Mullier, A Peeters, C Scavée, P Sinnaeve, M Sprynger, V Thijs, C Vandenbroeck, E Vandermeulen, P Verhamme, J M Dogné

Résultats de recherche: Contribution à un journal/une revueArticle de revueRevue par des pairs

841 Téléchargements (Pure)

Résumé

Rivaroxaban is one of the new oral anticoagulants (NOACs) (recommended as reference treatments when a long-term anticoagulation is needed). It has many potential advantages in comparison with Vitamin K Antagonists (VKA). It has a predictable anticoagulant effect and does not theoretically require biological monitoring. It is also characterized by less food and drug interactions. However, due to major risks associated with over- and under-dosage, its optimal use in patients should be carefully followed by health care professionals. The aim of this article is to provide recommendations for pharmacists on the practical use of Xarelto® in its different approved indications. This document is adapted from the practical user guide of rivaroxaban which was developed by an independent group of Belgian experts in the field of thrombosis and haemostasis.
Titre traduit de la contributionRivaroxaban: Xarelto® - Recommendations for pharmacists
langue originaleFrançais
Pages (de - à)28-36
Nombre de pages9
journalJournal de Pharmacie de Belgique
Numéro de publication1
Etat de la publicationPublié - 1 mars 2013

Empreinte digitale Examiner les sujets de recherche de « Rivaroxaban (Xarelto®): Guide de la pratique officinale ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation